Tag: XERS Stock

Business

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) Announces Relevant Securities in Issue as Per the Irish Takeover Rules

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) has announced that, as of the close of business on July 28, 2021, its issued share capital, excluding treasury shares, consists of around 66.497 common stock shares with a par value of $0.0001 per share, as per the Irish Takeover Panel Act, 1997’s Rule 2.10, […]